Cargando…

Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer

Colitis-associated colorectal cancer (CAC) develops from chronic intestinal inflammation. Dihydroartemisinin (DHA) is an antimalarial drug exhibiting anti-inflammatory and anti-tumor effects. Nonetheless, the therapeutic effects of DHA on CAC remain unestablished. Methods: Mice were challenged with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Bingjun, Wu, Fei, Ying, Kangkang, Xu, Yuzi, Shan, Lina, Lv, Yiming, Gao, Xing, Xu, Dengyong, Lu, Jun, Xie, Binbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120200/ https://www.ncbi.nlm.nih.gov/pubmed/33995655 http://dx.doi.org/10.7150/thno.55939

Ejemplares similares

Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer
por: Ying, Kangkang, et al.
Publicado: (2021)

Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Xu, Dengyong, et al.
Publicado: (2020)

Small molecule 2,3-DCPE induces S phase arrest by activating the ATM/ATR-Chk1-Cdc25A signaling pathway in DLD-1 colon cancer cells
por: Bai, Bingjun, et al.
Publicado: (2020)

Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer
por: Lv, Yiming, et al.
Publicado: (2019)

Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer
por: Xie, Binbin, et al.
Publicado: (2019)

Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels
por: Zhang, Chiming, et al.
Publicado: (2020)

A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
por: Lv, Yiming, et al.
Publicado: (2023)

Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer
por: Bai, Bingjun, et al.
Publicado: (2018)

Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer
por: Zheng, Wenqian, et al.
Publicado: (2021)

Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma
por: Kim, Suk Hee, et al.
Publicado: (2016)

Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level
por: Hu, Xianjing, et al.
Publicado: (2021)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

BMAL1 promotes colorectal cancer cell migration and invasion through ERK‐ and JNK‐dependent c‐Myc expression
por: Shan, Lina, et al.
Publicado: (2022)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
por: Li, Qingrong, et al.
Publicado: (2021)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2022)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2023)

Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2017)

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2022)

Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells
por: Ontikatze, Teona, et al.
Publicado: (2014)

A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients
por: Xu, Yuzi, et al.
Publicado: (2021)

Comparative genomic signatures in young and old Chinese patients with colorectal cancer
por: Wang, Fei, et al.
Publicado: (2021)

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2020)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenaf, et al.
Publicado: (2023)

Zinc Protoporphyrin-9 Potentiates the Anticancer Activity of Dihydroartemisinin
por: Zhang, Yu, et al.
Publicado: (2023)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers
por: Isnawati, Ani, et al.
Publicado: (2023)

Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells
por: Lucibello, Maria, et al.
Publicado: (2015)

Multidisciplinary evaluation of locally advanced leiomyosarcoma in the lower rectum: a case report and literature review
por: Xu, Dengyong, et al.
Publicado: (2019)

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
por: Li, Liu-Gen, et al.
Publicado: (2022)

Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells
por: Zhu, Wenhe, et al.
Publicado: (2018)

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2021)

Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo
por: Jiang, Cailing, et al.
Publicado: (2018)

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Preoperative radiotherapy for patients with rectal cancer: a risk factor for non-reversal of ileostomy caused by stenosis or stiffness proximal to colorectal anastomosis
por: Zhu, Hongbo, et al.
Publicado: (2017)

Effects of dihydroartemisinin on the gut microbiome of mice
por: Liu, Yanyan, et al.
Publicado: (2020)

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
por: Yang, Xiao-Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_foogd7n0aaejvvu0fbga4qum4a